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Abstract
Enterohemorrhagic Escherechia coli is a serious human pathogen causing bloody
diarrhea and hemolytic uremic syndrome. It is difficult to study in animal models, but
pathogenesis may be modeled in mice with the similar murine pathogen, Citrobacter
rodentium. C. rodentium does not cause disease in streptomycin-treated mice, suggesting
that it is competition with other facultative anaerobes that triggers pathogenesis.
Streptomycin-treated mice were co-colonized with C. rodentium and a commensal E. coli
strain. The intestinal microbiota of each group was observed over a 15-day period using
quantitative PCR. Colon weights were also measured over the same period. Results
indicate that the disease caused by competition is not similar to normal C. rodentium
pathogenesis. Further research is necessary to determine the precise mechanism of
pathogenesis in this experimental model. The outcome may provide new insight into
enterohemorrhagic E. coli prevention and treatment.
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Introduction
Enterohemorrhagic Escherichia coli
Enterohemorrhagic Escherichia coli (EHEC) is a rod-shaped Gram-negative
facultative anaerobe that causes bloody diarrhea and hemolytic uremic syndrome. It is a
member of the class of organisms known as attaching and effacing pathogens. In humans,
EHEC infections may be life-threatening, especially if hemolytic uremic syndrome,
which may lead to renal failure, develops. Perhaps the best known EHEC strain is E. coli
O157:H7, a virulent strain that was first reported as an intestinal pathogen in 1982 (1).
EHEC is commensal in ruminant animals, including cattle and deer, and is, therefore,
often spread by contact with ruminants, their feces, or ingestion of contaminated meat or
dairy products (2, 3).
Citrobacter rodentium as a Murine Model
The disease EHEC causes in humans is routinely modeled in mice with the
murine pathogen Citrobacter rodentium. Like EHEC, C. rodentium is an attaching and
effacing pathogen. EHEC does not cause disease in mice, and as has been noted, C.
rodentium is similar to EHEC in virulence factors and pathogenesis (4, 5). This model
has been proven effective and a further advantage in that C. rodentium is not pathogenic
to humans (5). While C. rodentium does not carry all the same virulence factors as
EHEC, the genes causing transmissible murine colonic hyperplasia are found in both C.
rodentium and EHEC (3). In both species, those genes are found on the locus of
enterocyte effacement (LEE), which is comprised of genes coding for a type III secretory
system, intimin, translocated intimin receptor (Tir), and the LEE regulator Ler, as well as
other gene products contributing to virulence (5).
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Symptoms of Disease Caused by Citrobacter rodentium
Although the classic symptoms of disease caused by pathogens such as EHEC
and C. rodentium include bloody diarrhea, mice infected with C. rodentium in the
laboratory may not have diarrhea. In such cases, pathogenesis is determined via
examination of feces and of the colon, as well as by histopathology. A conventional
mouse infected with C. rodentium will have softened feces and increased colon weight
when compared with a healthy mouse. These symptoms are due to breakdown of the
intestinal epithelial barrier and edema caused by inflammation. Upon histopathological
analysis, colonic hyperplasia and increased crypt height are visible (5).
Mechanism of Pathogenesis
Both C. rodentium and EHEC adhere to intestinal cells by means of attaching and
effacing lesions. Bacteria attach directly to the outer membranes of intestinal epithelial
cells, destroying brush-border microvilli in the immediate area. Successful attachment
and subsequent colonization results in colonic hyperplasia as well as inflammation.
To initiate attachment, effector proteins including Tir are injected into epithelial cells
with type III secretion systems.
Tir is inserted in the outer membrane of host epithelial cells; the extracellular
domain provides an attachment site for intimin, a bacterial adhesion factor. Intimin-Tir
interaction causes phosphorylation of Tir, which promotes the formation of actin-rich
pedestals to which the bacteria can attach. Tir is also instrumental in evading the infected
cell’s immune response and is upregulated in response to various stresses, including lack
of nutrients (6, 7).
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The disease caused by EHEC and C. rodentium disturbs the intestinal microbiota,
affects colonic mucus layers, and may disrupt the integrity of the epithelial barrier.
Intimin-Tir attachment is necessary for pathogenesis in EHEC and C. rodentium, but it is
not always necessary for colonization (2, 4, 8).
Colonization resistance and the nutrient-niche theory
Colonization of the gastrointestinal tract is the first step necessary for pathogens
to cause disease in a host. One of the primary barriers to pathogen colonization of the
intestine is the intestinal microflora (9). As a diverse ecosystem, the commensal intestinal
bacteria prevent colonization of new organisms by multiple forms of competition. Some
commensal species secrete substances that change the local environment, making it more
hostile to competitors. Other bacteria activate and then evade the host’s immunity when
presented with a new competitor (9).
Freter considered the most important part of colonization resistance to be
competition for nutrients, in what is now known as his nutrient-niche hypothesis.
According to Freter, invading bacterial species must grow faster than the washout rate for
successful intestinal colonization. They must also be able to outcompete commensal
species on at least one growth-limiting nutrient. Successful pathogens, then, are able to
find a particular niche in the nutrients available and exploit that niche in order to colonize
the intestine (10). Commensal bacteria that utilize the same nutrients as invading species
are often able to completely prevent colonization. However, an organism’s normal
microbiota, though stable, is in continuous flux. Specific bacterial strains may colonize
the intestine for long or short periods of time. When succession of strains occurs, a
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nutritional niche is left open temporarily, and any bacterium able to exploit the niche has
a chance to colonize.
Effect of pathogenesis on intestinal microbiota
About 800 species of bacteria are present in the human intestinal microbiota,
forming a complex ecosystem that plays critical roles in host health. Most species in the
intestine are obligate anaerobes, although some facultative anaerobes are present. Of the
facultative anaerobes, E. coli is the most prominent species. Major genera include
Bacteroidales, Clostridium, Lactobacillus, and Enterobacteraciae.
Relative abundances of each of these genera were previously measured in both
conventional and streptomycin-treated mice infected with C. rodentium. Bacteroidales
species showed an increase in relative population abundance in conventional mice
infected with C. rodentium as compared to controls; the abundance of the same genus
also increased in streptomycin-treated mice. Lactobacilli populations showed a
significant increase associated with C. rodentium colonization in both conventional and
streptomycin-treated mice, with the increase greatest in conventional mice. No significant
change was noted in the relative abundances of Clostridia, Bifidobacteria, or
Enterobacteraciae species with either streptomycin treatment or C. rodentium infection
(Figure 1) (11, 12).
Escherechia coli Strains
Three well-characterized commensal E. coli strains are commonly used in murine
models of EHEC infections: MG1655, HS, and Nissle. MG1655 is a human-commensal
K-12 strain of E. coli that has been studied in depth since it was first cultured in the early
twentieth century. It is the typical strain of E. coli used as a model organism and as such
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Figure 1. Comparison of bacterial population abundances in conventional and strep-treated
strep
mice
with and without CR infection. Population abundances were quantified using qPCR over a 15-day
15
period.
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is present in most molecular biology laboratories. Nissle was initially cultured in 1917
from a German soldier who showed low susceptibility to intestinal disorders. A highly
competitive strain in the mammalian intestine, it has been used as a probiotic and for
treatment of ulcerative colitis (13). E.coli HS was isolated in 1958 from a healthy
individual and is typically used to represent normal commensal strains. It is considered
closer to wild-type commensal E. coli than MG1655 or Nissle (2, 14).
Murine Models
Because of the complexity of the intestinal environment and ecosystem, in vivo
models are far superior. In vitro models are unable to precisely replicate the anaerobic
environment, intestinal mucus, or the intestinal bacterial community. Rodent, particularly
mouse, models are ideal for several reasons. Rodents and humans share similar intestinal
anatomy. Both species possess a large and small intestine with a duodenum and jejunum,
although mice have a large cecum when compared to the human appendix. Rodent diets
and environments are easily controlled, and many studies have proven that results from
rodent models are consistent with data obtained from humans (5).
Bacterial-host interactions are typically studied in gnotobiotic, conventional, or
streptomycin-treated mouse models. Gnotobiotic mice are raised in sterile environments.
They have no intestinal microbiota and so display no colonization resistance. This model
may be useful for studying the interaction between a specific bacterium and a host, but it
is unrealistic, as the complex interactions between the host and the intestinal community
as well as the microbiota-pathogen interactions are absent. Gnotobiotic mice also often
have a reduced immune system. Therefore, the gnotobiotic mouse model is not ideal for
studying interaction between bacteria in vivo (15).
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Conventional mice have their intestinal microbiota intact. This model is excellent
for studying pathogenesis, as it represents a normal mammalian internal environment.
Conventional mice, however, display colonization resistance as a result of their intact
microbiota, which can make studies that require intestinal colonization difficult. 24 hours
of streptomycin treatment before inoculation opens a nutritional niche, allowing
facultative anaerobes such as C. rodentium to colonize the intestine more easily. The
effects of streptomycin last about 48 hours, after which the normal facultative anaerobes
begin to recolonize the intestine (4, 5, 16).
Streptomycin treatment may also be continued throughout experimentation. This
approach has the advantage of causing minimal changes in the intestinal microbiota
during experiments, as the disturbance due to antibiotic treatment occurs before
inoculation. The streptomycin-treated mouse model reduces facultative anaerobes in the
murine intestine to less than the lower limit of screening protocols (102 CFU), allowing
study of specific facultative interactions in vivo while preserving interaction with other
members of the intestinal microbiota (4).
Streptomycin is the antibiotic of choice because it targets facultative anaerobes as
well as causing mild intestinal irritation, a state in which more nitrates are available for
bacterial metabolism (17). Furthermore, when streptomycin is compared to other
antibiotics such as metronidazole, it does not significantly alter either the gastrointestinal
mucus layer or the intestinal microbiota (16).
C. rodentium causes disease in conventional mice; however, it does not do so in
streptomycin-treated mice, as shown in Figure 2. Conventional mice given a burst of
streptomycin treatment before inoculation show no pathogenesis initially. Disease
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develops later and has been associated with normalization of the intestinal microbiota.
Streptomycin-treated mice, then, are useful for studying the interactions between
intestinal microbiota and bacteria such as C. rodentium before pathogenesis occurs.
Colonization versus pathogenesis
Colonization and pathogenesis are assumed to occur together in most models of
intestinal disease. The ability of C. rodentium to colonize the streptomycin-treated mouse
intestine without pathogenesis occurring is significant, demonstrating that colonization is
not sufficient for pathogenesis. The primary difference between conventional and
streptomycin-treated mice lies with the absence of facultative anaerobes in the latter. It is
reasonable to assume, then, that interaction with other facultative anaerobes drives
pathogenesis. Competition of C. rodentium with certain E. coli strains causes
pathogenesis by a currently unknown mechanism. If the competition-induced disease
state is similar to disease caused by C. rodentium in conventional mice, inducing
pathogenesis via competition will be relevant to EHEC modeling. If competition-induced
disease in streptomycin-treated mice is similar to the pathogenesis in conventional mice,
it is possible that C. rodentium and, by extension, EHEC and other attaching and effacing
pathogens, cause disease primarily through competition with commensal facultative
anaerobes. One possible mechanism for competition-induced disease involves intimin
and Tir. Intimin is necessary for C. rodentium to successfully colonize the murine
intestine, while Tir is needed for attachment and pathogenesis, but not necessarily
colonization (6, 8). Stress from direct competition with another facultative anaerobe for
nutrients may trigger intimin-Tir attachment in C. rodentium, leading to pathogenesis.
I hypothesize that competition-induced disease in streptomycin-treated mice will
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Figure 2.. Colon weights from various conventional and streptomycin
streptomycin-treated
treated mice. CD-1, BALB-C,
C57B1/6, and C3H/HeN mice were fed 1010 CFU of C. rodentium , and the colons were harvested at days
3, 5, and 7 post infection. The increase in edema for the conventional mice is indicated by an increase in
colon weights. There was no measurable edema in strep
strep-treated
treated mice. Edema is a measurable symptom of
C. rodentium pathogenesis, and so this data indicates that streptomycin
streptomycin-treated
treated mice do not experience
disease due to C. rodentium.
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resemble disease caused by C. rodentium in conventional mice and that changes in the
intestinal microbiota will also be similar. Competition with all strains of E. coli is not
expected to yield pathogenesis. Only facultative anaerobes in direct competition with C.
rodentium should provide the necessary stress to C. rodentium for initiation of disease.
The E. coli strains in this experiment most likely to cause competitive pathogenesis are
HS and Nissle, which are better suited than MG1655 for competition within the host’s
intestine (13).
Materials and Methods
Streptomycin-treated Mouse Model
12 CD-1 male mice were given sterile water containing streptomycin sulfate
(5g/L) starting at least 48 hours prior to inoculation and continuing throughout the
experiment. All mice were ordered from Charles River Laboratories. 24 hours after
streptomycin treatment began, the mice were starved of food and water for 18-24 hours.
Oral inoculation was carried out via a suspension of bacteria in a 20% sucrose solution.
Suspensions contained 105 CFU C. rodentium and one E. coli strain of the following:
MG1655, HS, and Nissle. Strain combinations were as follows: C. rodentium and
MG1655, C. rodentium and HS, and C. rodentium and Nissle. Nine mice were infected
with each combination. Once the suspension was consumed, food and streptomycin water
were returned. 1 gram of fecal matter was collected from each mouse on days 1, 3, 5, and
7 post-inoculation. One mouse from each group was euthanized by carbon dioxide
inhalation and cervical dislocation after each collection, for a total of three mice
euthanized per collection. The cecum and colon was removed from each euthanized
mouse and weighed.
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Bacterial Strains and Growth Conditions
E. coli strains MG1655, HS, and Nissle were used, as well as C. rodentium
DBS100. All strains used were streptomycin-resistant. Bacteria were initially cultured in
Luria-Bertani broth with streptomycin at 37 °C. Fecal samples were plated on
MacConkey agar with streptomycin and incubated at 37 °C.
Fecal gDNA Isolation
Genomic DNA (gDNA) was isolated from stool samples from each collection
with the QIAamp DNA Stool Mini Kit (Catalog #51504) (Qiagen), according to the
manufacturer’s instructions. Concentration of gDNA was determined by measuring the
absorbance at 260 nm with a NanoDrop 2000 Spectrophotometer (Thermo Scientific).
Quantitative PCR of Genomic DNA
Quantitative PCR (qPCR) was performed on gDNA isolated from each stool sample.
SsoFast EvaGreen SuperMix (BioRad #172-5200) was used, along with the primers
shown in Table 1. 15 minutes of cycles at 95 °C were used, then 40 cycles of 94 °C for
15 seconds, 60 °C for 30 seconds, and 72 °C for 30 seconds (16). Primer accuracy was
first tested on pure cultures. Amplification start was recorded at a cycle number (Cq)for
every genus measured; the Cq for the total bacteria served as a standard against which to
measure specific bacterial abundances. The change in Cq (∆Cq) was calculated and was
then used to calculate relative population abundance by raising 2 to the value of the -∆Cq.
Results
Colon weight
Mice co-colonized with C. rodentium and E. coli HS or Nissle showed elevated
colon weights (Figure 3). Mice co-colonized with C. rodentium and MG1655
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Table 1. Primers for qPCR
Target 16S rRNA

Primer

Sequence

Reference

Eubacteria (total

UniF340

ACTCCTACGGGAGGCAGCAGT

(16)

bacteria)

UniR514

ATTACCGCGGCTGCTGGC

Bacteroidales

BactF285

GGTTCTGAGAGGAAGGTCCC

UniR338

GCTGCCTCCCGTAGGAGT

Bifidobacterium

Bif164F
Bif662R

GGGTGGTAATGCCGGATG

(16)

CCACCGTTACACCGGGAA

Clostridium

UniF338

ACTCCTACGGGAGGCAGC

coccoides

CcocR491

GCTTCTTAGTCAGGTACCGTCAT

Enterobacteriaceae

Coli F

GTGCCAGCMGCCGCGGTAA

Coli R

GCCATAACGTTGAAAGATGG

LabF362

AGCAGTAGGGAATCTTCCA

LabR677

CACCGCTACACATGGAG

Lactobacillus

(16)

(16)

(16)

(16)
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Figure 3. Colon weights for mice co-colonized with C. rodentium and HS, Nissle, or MG1655. Cocolonization of C. rodentium with all E. coli strains induces edema in the colon comparable to that found in
conventional mice infected by C. rodentium alone.
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also showed elevated colon weights, contrary to expectations. Elevated colon weight is
associated with inflammation and edema and is thus a reliable indicator of pathogenesis
for intestinal pathogens such as C. rodentium.
A notable spike in colonic weight occurred at day 3 in the mice colonized with
both C. rodentium and MG1655; however, this is likely due to an unusual amount of
feces observed in the colon at that time, rather than being caused solely by edema (Figure
3). Softened stools, another symptom of C. rodentium pathogenesis, were first observed
on day 5 in mice infected with both C. rodentium and Nissle (Figure 4) (18).
Quantitative PCR results
Analysis of the commensal bacteria in mice co-colonized with HS or Nissle
showed changes in relative distribution that were different from the changes in response
to C. rodentium colonization and pathogenesis in conventional mice. At day 1 postinoculation, each group of mice had a different genus dominant in the intestine;
Clostridia for mice co-colonized with C. rodentium and MG1655, Lactobacilli for those
with C. rodentium and HS, and both Clostridia and Bacteriodales in those colonized with
C. rodentium and Nissle (Figures 5-8). Day 3 post-inoculation shows a marked increase
in Clostridia species in mice colonized with C. rodentium and HS. Lactobacilli species
also increased in the C. rodentium and MG1655 mice, but decreased in those cocolonized with C. rodentium and HS (Figures 5-8). At day 5 post-inoculation, Clostridia
species have largely died off in mice colonized with C. rodentium and HS, but continue
to be numerous in mice infected with C. rodentium and MG1655 or Nissle. Bacteriodales
species have also bloomed in the C. rodentium and Nissle mice (Figures 5-8).
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Figure 4. Comparison of ceca and colons to demonstrate pathogenesis. The colon on the left was taken
from a mouse one day post-inoculation with C. rodentium and Nissle. The colon on the right was harvested
five days post-inoculation from a mouse infected with the same bacteria. Discrete fecal pellets have formed
in the entirety of the colon shown at left but only form in the last third of the colon at right.
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Abundance
(% of total 16S rRNA gene copies)

0.02

0.015
Bacteriodales
Clostridia
0.01
Lactobacilli
Bifidobacteria
Enterobacteraciae

0.005

0
CR+MG1655

CR+HS

CR+Nissle

Figure 5. Relative abundances of major intestinal genera at day 1 post-inoculation. Mice in which C.
rodentium is co-colonized with Nissle have relatively low abundances of Clostridia and high abundances of
Bacteriodales. Co-colonization with HS and MG1655, however, produces high abundances of Lactobacilli
and Clostridia, respectively.
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Figure 6. Relative abundances of major intestinal genera at day 3 post-inoculation. Compared to day 1
post-inoculation, Lactobacillus has increased relative to the total population in mice co-colonized with
MG1655, although it has decreased in those co-colonized with HS. Enterobacteraciae show an increase in
both. Mice co-colonized with Nissle show significantly more Clostridia than any other species.
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Abundance
(% of total 16S rRNA gene copies)

0.002

0.0015
Bacteriodales
0.001

Clostridia
Lactobacilli
Bifidobacteria

0.0005

Enterobacteraciae
5E-18
CR+MG1655

CR+HS

CR+Nissle

-0.0005
Figure 7. Relative abundances of major intestinal genera at day 5 post-inoculation. At day 7 postinoculation, mice in which C. rodentium is co-colonized with MG1655 or Nissle have a bloom of
Clostridia species, while the same genus is much reduced in HS. Mice colonized with C. rodentium and
Nissle also had an increase in Bacteriodales.
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Abundance
(% of total 16S rRNA gene copies)
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Bacteriodales
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Figure 8. Relative abundances of major intestinal genera at day 7 post-inoculation. By day 7 postinoculation, Clostridia and Lactobacilli species are dominant in the intestine. Mice colonized with both C.
rodentium and MG1655 have higher proportions of Lactobacilli than Clostridia, while the reverse is true
for mice co-colonized with C. rodentium and HS.
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By the seventh day after inoculation, Clostridia and Lactobacilli are the dominant
genera in all groups of mice. Mice colonized with both C. rodentium and
MG1655 have higher proportions of Lactobacilli than Clostridia, while the reverse is true
for mice co-colonized with C. rodentium and HS (Figures 5-8). Population abundances
for the genera measured showed little similarity to those measured in C. rodentiuminfected conventional mice treated with streptomycin.
Discussion
The characteristics of pathogenesis of C. rodentium intitiated by competition with
E. coli strains indicates that in conventional mice, disease is caused by competition with
commensal facultative anaerobes, including normal E. coli strains. The absence of
disease in mice co-colonized with C. rodentium and MG1655 further supports this
conclusion. MG1655 is a subset of the well-established E. coli laboratory strain K-12. HS
and Nissle are equally well-known, but they are closer to wild-type intestinal E. coli.
Nissle in particular is known to have multiple traits that increase its ability to
survive in the mammalian intestine, and in a host with a compromised intestinal
ecosystem, Nissle has been observed to outcompete the present bacteria and cause
pathogenesis(13, 19). HS is a typical commensal strain of E. coli , so pathogenesis by
competition with HS supports the hypothesis that the diseased caused by C. rodentium is
caused by competition in conventional mice as well as in streptomycin-treated models
(13).
Conclusion
Competition-induced disease has similar physical effects on the intestine when
compared with the disease caused in conventional mice by C. rodentium; however, it has
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very different effects on the intestinal microbiota. Competition appears to affect the
intestinal ecosystem in a way that decreases population stability, leading to rapid
succession of commensal intestinal genera. These conditions appear particularly
favorable to Clostridia species, judging by the frequency with which that genus was
dominant in co-colonized mice. Lactobacilli species also appeared to benefit, although
the populations were unstable. Co-colonization with C. rodentium and Nissle seems to
produce conditions unfavorable to Lactobacilli growth in the early stages of infection
(Figures 5-8). By day 7 post-inoculation, though, increased colon weights indicated
disease in all groups, and the intestinal microbiota of each group was dominated by
Clostridia and Lactobacillus species. It may be inferred that competitive disease produces
an environment more favorable to those genera than to other intestinal bacteria, although
confirmation would require analysis of samples taken beyond day 7 after inoculation.
This conclusion is based solely on measuring inflammation and edema via colon
weight and on the changes in commensal intestinal microbiota as measured by
quantitative PCR. Future collections of histopathological data are needed to gauge the
true similarity of competition-induced disease to that caused in conventional mice.
The lack of similarity of competition-induced disease to pathogenesis of C.
rodentium in conventional mice indicates that competition with commensal facultative
anaerobes may not be the normal cause of pathogenesis. This conclusion can be extended
to EHEC; however, further confirmation using a model susceptible to EHEC is necessary.
Several possible mechanisms are possible to explain competition-induced
pathogenesis of attaching and effacing pathogens. Intimin is necessary for C. rodentium
to colonize the murine intestine successfully, while Tir is needed for both attachment and
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pathogenesis but not necessarily colonization (7, 8). Expression of LEE-encoded
virulence factors has been observed to increase or decrease in response to environmental
factors, including the presence of other members of the intestinal microbiota (20).
Furthermore, proteins involved in stress responses, such as RegA, have been shown to
upregulate LEE gene expression (19, 21). Therefore, stress from direct competition for
nutrients with another facultative anaerobe may increase the expression of genes on the
LEE, including Tir. Intimin-Tir attachment follows, leading to pathogenesis.
Another, similar possibility is that the type III secretion system present in
attaching and effacing pathogens is activated by the stress of competition, injecting Tir
and associated proteins into host cells in order for intimin-Tir attachment to occur (19,
21). Further studies on the gene regulation of Tir and other LEE genes during
competition are necessary for a more detailed hypothesis.
Although competition-induced disease shows little similarity to the disease
normally caused by C. rodentium, understanding various causes of pathogenesis for
attaching and effacing pathogens may lead to effective treatments and preventions for
disease caused by EHEC in humans. There is no treatment currently available for EHEC
infections; many antibiotics cause an increase in virulence factor expression, which
increases patients’ risk of developing hemolytic uremic syndrome (22). Based on the
results of this study, attaching and effacing pathogens such as EHEC and C. rodentium
display virulence in the mammalian intestine, although not because of competition with
other facultative anaerobes. The effects that competitive disease has on destabilizing the
intestinal microbiota suggest that during rapid succession of intestinal strains during
pathogenesis, other pathogens may be able to colonize the intestine and cause disease
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(10). If the commensal microbiota, especially facultative anaerobes, can be manipulated
to reduce competition with EHEC, the destabilization of the commensal ecosystem may
be reduced or avoided. For such treatment to be viable, more studies on the normal
intestinal microbiota and their interactions are necessary.

27

COLONIZATION OF INTESTINAL PATHOGEN
References
1.

2.
3.
4.

5.
6.
7.
8.

9.
10.

11.
12.
13.

14.
15.

M. R. Laidler et al., Escherichia coli O157:H7 infections associated with
consumption of locally grown strawberries contaminated by deer. Clinical
infectious diseases : an official publication of the Infectious Diseases
Society of America 57, 1129-1134 (2013).
R. E. Besser, P. M. Griffin, L. Slutsker, Escherichia coli O157:H7
gastroenteritis and the hemolytic uremic syndrome: an emerging infectious
disease. Annual review of medicine 50, 355-367 (1999).
J. L. Mellies, A. M. Barron, A. M. Carmona, Enteropathogenic and
enterohemorrhagic Escherichia coli virulence gene regulation. Infection
and immunity 75, 4199-4210 (2007).
W. Deng, B. A. Vallance, Y. Li, J. L. Puente, B. B. Finlay, Citrobacter
rodentium translocated intimin receptor (Tir) is an essential virulence
factor needed for actin condensation, intestinal colonization and colonic
hyperplasia in mice. Molecular microbiology 48, 95-115 (2003).
R. Mundy, T. T. MacDonald, G. Dougan, G. Frankel, S. Wiles, Citrobacter
rodentium of mice and man. Cellular microbiology 7, 1697-1706 (2005).
T. Dong, B. K. Coombes, H. E. Schellhorn, Role of RpoS in the virulence
of Citrobacter rodentium. Infection and immunity 77, 501-507 (2009).
K. R. Haack, C. L. Robinson, K. J. Miller, J. W. Fowlkes, J. L. Mellies,
Interaction of Ler at the LEE5 (tir) operon of enteropathogenic Escherichia
coli. Infection and immunity 71, 384-392 (2003).
W. Deng, Y. Li, B. A. Vallance, B. B. Finlay, Locus of enterocyte
effacement from Citrobacter rodentium: sequence analysis and evidence
for horizontal transfer among attaching and effacing pathogens. Infection
and immunity 69, 6323-6335 (2001).
I. Sekirov, B. B. Finlay, The role of the intestinal microbiota in enteric
infection. The Journal of physiology 587, 4159-4167 (2009).
A. J. Fabich et al., Comparison of carbon nutrition for pathogenic and
commensal Escherichia coli strains in the mouse intestine. Infection and
immunity 76, 1143-1152 (2008).
C. Black, Liberty University, (2014).
D. A. Rasko et al., The pangenome structure of Escherichia coli:
comparative genomic analysis of E. coli commensal and pathogenic
isolates. Journal of bacteriology 190, 6881-6893 (2008).
K. Gronbach et al., Safety of probiotic Escherichia coli strain Nissle 1917
depends on intestinal microbiota and adaptive immunity of the host.
Infection and immunity 78, 3036-3046 (2010).
A. L. Lloyd, D. A. Rasko, H. L. Mobley, Defining genomic islands and
uropathogen-specific genes in uropathogenic Escherichia coli. Journal of
bacteriology 189, 3532-3546 (2007).
Y. Umesaki, Use of gnotobiotic mice to identify and characterize key
microbes responsible for the development of the intestinal immune
system. Proceedings of the Japan Academy. Series B, Physical and
biological sciences 90, 313-332 (2014).

28

COLONIZATION OF INTESTINAL PATHOGEN
16.
17.
18.
19.

20.
21.

22.

M. Wlodarska et al., Antibiotic treatment alters the colonic mucus layer
and predisposes the host to exacerbated Citrobacter rodentium-induced
colitis. Infection and immunity 79, 1536-1545 (2011).
A. M. Spees et al., Streptomycin-induced inflammation enhances
Escherichia coli gut colonization through nitrate respiration. mBio 4,
(2013).
R. Mundy et al., Identification of a novel Citrobacter rodentium type III
secreted protein, EspI, and roles of this and other secreted proteins in
infection. Infection and immunity 72, 2288-2302 (2004).
E. Hart et al., RegA, an AraC-like protein, is a global transcriptional
regulator that controls virulence gene expression in Citrobacter rodentium.
Infection and immunity 76, 5247-5256 (2008).
C. L. Ohland, W. K. Macnaughton, Probiotic bacteria and intestinal
epithelial barrier function. American journal of physiology. Gastrointestinal
and liver physiology 298, G807-819 (2010).
A. Tan et al., Evolutionary Adaptation of an AraC-Like Regulatory Protein
in Citrobacter rodentium and Escherichia Species. Infection and immunity
83, 1384-1395 (2015).
M. Mor, S. Ashkenazi, The dilemma of antimicrobial treatment of Shiga
toxin-producing Escherichia coli. The Pediatric infectious disease journal
33, 979-981 (2014).

29

